Talazoparib Maintenance Therapy in Triple-negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: TNBC - Triple-Negative Breast Cancer
Interventions: DRUG: Talazoparib|DRUG: Placebo
Sponsor: Yonsei University